# ROPIVACAINE HYDROCHLORIDE
> **ANDA210102** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2022-08-18
## Drug
- **FDA Application Number:** ANDA210102
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ROPIVACAINE HYDROCHLORIDE
- **Generic name:** ROPIVACAINE HYDROCHLORIDE
- **Active ingredients:** ROPIVACAINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Gland Pharma Limited
- **First approval:** 2022-08-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210102)
---
*MORVS · CC0 1.0*